BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME;VALUE=TEXT:Commercializing Innovation: Prof. Doug Melton and Semma Therapeutics
PRODID:-//Harvard events data//EN
BEGIN:VEVENT
UID:event_1050656_0
SUMMARY:Commercializing Innovation: Prof. Doug Melton and Semma Therapeutics
DESCRIPTION:<p>Featuring cofounders of Harvard-launched startup Semma Therapeutics:</p><div class="full-length-border"><article class="content-main media-main col7 push1 media-article news-update" style="position: relative;"><ul><li><strong>Douglas A. Melton, PhD</strong>, Xander University Professor and Thomas Dudley Cabot Professor in the Natural Sciences, Harvard University; co-director of the Harvard Stem Cell Institute</li><li><strong>Felicia Pagliuca, PhD</strong>, Vice President of Cell Biology Research and Development, Semma Therapeutics</li><li><strong>Robert Millman, JD</strong>, CEO of Semma Therapeutics</li></ul><p>The Commercializing Innovation speaker series is primarily intended for Harvard University faculty, postdoctoral researchers, and graduate students who are interested in learning about technology commercialization, careers outside of academia, and scientific entrepreneurship. However, the event is open to all.</p><p>To register, go <a data-url="http://otd.harvard.edu/events/commercializing-innovation-prof-doug-melton-and-semma-therapeutics" href="http://otd.harvard.edu/events/commercializing-innovation-prof-doug-melton-and-semma-therapeutics" target="_blank" title="">here</a></p><p>Hosted by Harvard Office of Technology Development and the FAS Office of Postdoctoral Affairs.</p></article></div><p> </p>
LOCATION:Biolabs 1080, 16 Divinity Ave., Cambridge
STATUS:CONFIRMED
DTSTART:20170424T200000Z
DTEND:20170424T220000Z
END:VEVENT
END:VCALENDAR